Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Audio Podcast - John B. Buse, MD, PhD - An Update on SGLT2 Inhibition for the Prevention and Treatment of Kidney Disease in Patients With Type 2 Diabetes

John B. Buse, MD, PhD - An Update on SGLT2 Inhibition for the Prevention and Treatment of Kidney Disease in Patients With Type 2 Diabetes

PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Audio Podcast

07/05/19 • 40 min

plus icon
bookmark
Share icon
Go online to PeerView.com/XRN860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in endocrinology discusses the clinical potential of SGLT2 inhibitors for the prevention and treatment of kidney disease in patients with type 2 diabetes. Upon completion of this activity, participants should be better able to: Review the proposed mechanism(s) that support the clinical potential of SGLT2 inhibitors to provide renal protection in patients with type 2 diabetes, Assess the evidence evaluating the potential of SGLT2 inhibitors to prevent and/or treat kidney disease in patients with type 2 diabetes.

07/05/19 • 40 min

plus icon
bookmark
Share icon

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/peerview-kidney-and-genitourinary-diseases-cmecnecpe-audio-podcast-25531/john-b-buse-md-phd-an-update-on-sglt2-inhibition-for-the-prevention-an-4346898"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to john b. buse, md, phd - an update on sglt2 inhibition for the prevention and treatment of kidney disease in patients with type 2 diabetes on goodpods" style="width: 225px" /> </a>

Copy